Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.

Aksam YassinAhmad HaiderKarim S HaiderMonica CaliberGheorghe DorosFarid Saad W Timothy Garvey

Published in: Diabetes care (2019)

Long-term TTh completely prevents prediabetes progression to T2D in men with hypogonadism and improves glycemia, lipids, and AMS score. TTh holds tremendous potential for the large and growing population of men with prediabetes and hypogonadism.

Keyphrases

replacement therapy
type diabetes
middle aged
smoking cessation
mouse model
cardiovascular disease
electronic health record
big data
glycemic control
risk assessment
stem cells
mesenchymal stem cells
fatty acid
weight loss
data analysis